Best Diagnostics & Research stocks: industry ranking by MarketKingdoms score

13 Diagnostics & Research companies are scored. Their average composite is 68.1, and 0 are in the A range (76+). The leader is Illumina Inc. (ILMN) at 71.2 (B+). This industry belongs to the Healthcare sector.

Diagnostics & Research lens averages

• Industry opportunity: 90
• Stock selection: 83
• KPI momentum: 85
• Catalyst watch: 77
• Price (valuation): 32
• Expansion (growth): 52
• Quality (profitability): 42
• Trend (momentum): 69

All Diagnostics & Research companies ranked

#	Company	Composite	Grade	Industry opportunity	Stock selection	KPI momentum	Catalyst watch	Price	Expansion	Quality	Trend	Valuation gap
1	Illumina Inc. (ILMN)	71.2	B+	90	84	87	80	14	46	66	86	+22.1%
2	Agilent Technologies Inc. (A)	69.3	B	90	84	88	80	31	52	56	69	-3.1%
3	Quest Diagnostics Incorporated (DGX)	69.2	B	90	84	87	80	56	51	43	63	-4.1%
4	Revvity Inc. (RVTY)	69.2	B	90	85	93	79	32	41	40	91	+8.2%
5	Labcorp Holdings Inc. (LH)	69.0	B	90	87	93	73	59	44	34	56	-13.5%
6	IQVIA Holdings Inc. (IQV)	68.9	B	90	86	93	72	51	52	38	79	-16.5%
7	Natera Inc. (NTRA)	68.6	B	90	87	93	77	6	93	16	88	-22.9%
8	Charles River Laboratories International Inc. (CRL)	68.2	B	90	87	84	82	29	27	17	93	-15.8%
9	Waters Corp. (WAT)	68.0	B	90	86	86	76	28	77	25	74	-6.2%
10	Thermo Fisher Scientific Inc. (TMO)	67.3	B	90	79	82	78	33	47	41	65	-11.9%
11	Idexx Laboratories Inc. (IDXX)	66.3	B	90	74	67	73	22	65	77	17	-16.0%
12	Danaher Corp. (DHR)	65.1	B	90	75	72	73	33	47	49	53	-9.5%
13	Mettler-Toledo International Inc. (MTD)	64.8	B	90	80	82	72	18	39	44	62	+3.9%

Diagnostics & Research leaders on each lens

• Industry opportunity: A 90, CRL 90, DGX 90
• Stock selection: CRL 87, LH 87, NTRA 87
• KPI momentum: IQV 93, LH 93, NTRA 93
• Catalyst watch: CRL 82, A 80, DGX 80
• Price (valuation): LH 59, DGX 56, IQV 51
• Expansion (growth): NTRA 93, WAT 77, IDXX 65
• Quality (profitability): IDXX 77, ILMN 66, A 56
• Trend (momentum): CRL 93, RVTY 91, NTRA 88

How MarketKingdoms scores companies

The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.

General information, not investment advice.